Zobrazeno 1 - 10
of 620
pro vyhledávání: '"A. A. Epenetos"'
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss S1, Pp S15-S15 (2021)
Externí odkaz:
https://doaj.org/article/18fc3877ebf64a1c96fe0a88da238ce4
Publikováno v:
Journal of Clinical Oncology. 40:96-96
96 Background: The tumor suppressor gene TP53 is one of the most frequently deleted or mutated genes in gastrointestinal cancers. Normal p53 regulates several important proteins that control cell cycle, cell death, DNA damage/repair, stemness, differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4569ffc06a858320eb21519036c4dc9b
https://doi.org/10.1200/jco.2022.40.4_suppl.096
https://doi.org/10.1200/jco.2022.40.4_suppl.096
Autor:
Balkwill, Fran, Schlom, Jeffrey, Berek, Jonathan, Epenetos, Aga, Bookman, Michael, Freedman, Ralph, Wilbanks, George
Publikováno v:
In Gynecologic Oncology 2003 88(1) Supplement:S110-S113
Autor:
Konstantinos Kapnisis, Agamemnon A. Epenetos, Christina Kousparou, Marianna Prokopi, Andreas S. Anayiotos, Mahendra Deonarain, Costas Pitsillides
Publikováno v:
Journal of Clinical Oncology. 38:e17601-e17601
Presented in American Society of Clinical Oncology Annual Meeting, 2020 Notch signalling is implicated in tumorigenesis prompting scientists to research and develop anti-Notch therapeutics. Drugging the Notch pathway has been a challenge due to sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219c1de6fb2dbff33d2bd149f1e17867
https://doi.org/10.1200/jco.2020.38.15_suppl.e17601
https://doi.org/10.1200/jco.2020.38.15_suppl.e17601
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 338 (2012)
Abstract Background A significant number of cancers are caused by defects in p21 causing functional defects in p21 or p53 tumour-suppressor proteins. This has led to many therapeutic approaches including restoration by gene therapy with wild-type p53
Externí odkaz:
https://doaj.org/article/460018ad7d6f42538a49b02262595070
Publikováno v:
Cancer Therapy with Radiolabeled Antibodies ISBN: 9781351070409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::044482fa4e9421d4794848ed0045d782
https://doi.org/10.1201/9781351070409-12
https://doi.org/10.1201/9781351070409-12
Publikováno v:
Delivery Strategies for Antisense Oligonucleotide Therapeutics ISBN: 9781315150901
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45b767a353c486d7165af2d895791c5
https://doi.org/10.1201/9781315150901-18
https://doi.org/10.1201/9781315150901-18
Autor:
Pericleous, L. M.1, Richards, J.1, Epenetos, A. A.1, Courtenay-Luck, N.2, Deonarain, M. P.1 m.deonarain@imperial.ac.uk
Publikováno v:
British Journal of Cancer. 11/28/2005, Vol. 93 Issue 11, p1257-1266. 10p.
Publikováno v:
Acta Oncologica. Oct2001, Vol. 40 Issue 5, p549-557. 9p. 1 Chart.
Autor:
Peters, A. M., Lavender, J. P., Needham, S. G., Loutfi, I., Snook, D., Epenetos, A. A., Lumley, P., Keery, R. J., Hogg, N.
Publikováno v:
British Medical Journal (Clinical Research Edition), 1986 Dec . 293(6561), 1525-1527.
Externí odkaz:
https://www.jstor.org/stable/29525435